SWAN CORP
SWANCORP · NSEValuation
Blended fair value using DCF and peer comparison methods.
Peer comparison
How this company stacks up against sector peers on valuation and quality metrics.
Specialty chemicals · 8 peers · sector medians shown
| Company | Mkt Cap | P/E | P/B | EV/EBITDA | ROE | Net Margin | Rev CAGR 3y |
|---|---|---|---|---|---|---|---|
SWAN CORP SWANCORP · you | ₹10,003 Cr | 36.9× | 1.3× | -56.5× | 3.6% | 6.3% | 44.9% |
| Sector median | — | 45.3× | 3.5× | 24.7× | 9.2% | 7.1% | 4.4% |
| Navin Fluorine International NAVINFLUOR | ₹35,059 Cr | 52.3× | 8.8× | 33.5× | 16.7% | 20.0% | 16.8% |
| Himadri Speciality Chemical HSCL | ₹34,271 Cr | 45.3× | 7.3× | 34.1× | 16.0% | 16.1% | 3.8% |
| Deepak Nitrite DEEPAKNTR | ₹22,820 Cr | 41.3× | 3.9× | 24.7× | 9.4% | 7.0% | -0.4% |
| Atul ATUL | ₹19,511 Cr | 28.9× | 3.1× | 19.1× | 10.9% | 10.8% | 4.9% |
| Tata Chemicals TATACHEM | ₹19,007 Cr | — | 0.9× | — | -8.9% | -13.0% | -4.6% |
| Anupam Rasayan India ANURAS | ₹14,429 Cr | 84.0× | 4.3× | 28.5× | 5.1% | 7.2% | 13.9% |
| PCBL Chemical PCBL | ₹11,243 Cr | 55.1× | 2.8× | 14.2× | 4.9% | 2.4% | 12.4% |
| Jubilant Ingrevia JUBLINGREA | ₹9,931 Cr | 35.7× | 3.2× | 18.5× | 8.9% | 6.3% | -2.8% |
SWAN trades at a discount to sector peers on P/E (36.9× vs median 45.3×). This may signal undervaluation — or reflect lower expected growth or higher perceived risk versus the peer group.
Business quality
Key profitability, efficiency, and solvency metrics.
Financial health
Piotroski F-Score, Altman Z-Score, and key solvency ratios.
Full financial data
Charts and annual statements for income, balance sheet and cash flow.
Income trend
Revenue, profit and margin trends over time.
Cash flow
Where cash comes from and where it goes.
Balance sheet
Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.
How the company is funded — equity is owners' money, debt is long-term borrowing, current liabilities are short-term obligations.